Detection of Low Bone Mineral Density Using Lung Cancer Screening Low-dose Computerized Tomography
Danielle Soldin, M. Ali, Harinderjit Singh Gill, Allison Herring, W.R. Grier, Janaki Deepak
University of Maryland, Baltimore
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Objective: We aim to determine the rate of decreased bone mineral density in the lung cancer screening population to develop best practices for screening for these comorbid conditions during annual lung cancer screening low-dose computerized tomography (LDCT) scans. We hope that recognizing osteopenia on annual lung cancer screening exams will lead to early recognition and treatment of low bone mineral density in this population. Methods/Materials: We evaluated 226 patients enrolled in the Lung Cancer Screening Program at the Baltimore Veterans Health Administration between April 2014- January 2022. Of these, 144 were excluded for use of 100kv technique. Of the remaining 82 scans, a total of 54 LDCTs were found to have evidence of decreased bone mineral density in the radiology read. Bone density was measured on LDCTs performed using 120kv technique with measurements made on the L1 and T12 vertebral bodies using a threshold of 160 HU for osteopenia and 110 HU for osteoporosis. Patient charts were then examined for Dual X-ray Absorptiometry (DEXA) scan reports and the lowest T scores were noted. Charts were reviewed for start dates of pharmacological treatments of osteopenia and osteoporosis including calcium supplements, vitamin D, bisphosphonates, denosumab, Selective Estrogen Receptor Modulators (SERMs) like tamoxifen and raloxifene. Finally, imaging obtained subsequent to the LDCT was reviewed for the word “fracture” to determine if the patients had any new fractures following the LDCT. Patients were not counted as having new fractures if fractures were described as “old” or “healed.” Results: In the examined cohort, 12/54 (22%) demonstrated osteoporosis and 20/54 (37%) demonstrated osteopenia. A total of 32/54 (59%) demonstrated decreased bone mineral density. Only 5/54 (9.2%) patients had had DEXA scans prior to their LDCT, and 10/54 (18%) patients had DEXA scans following their LDCT. Of this cohort, 17/54 (31%) were started on new therapy for decreased bone mineral density, 26/54 (48%) were continued on their existing treatment plan, and 11/54 (20%) were not provided therapy for low bone mineral density. New fractures were noted in 4/54 (7.4%) of the cohort. Conclusions: Lung cancer screening LDCTs can aid in detection of low bone mineral density as 32/54 patients (59%) had either osteoporosis or osteopenia. Identifying these patients using this modality can aid in earlier detection and treatment of low bone mineral density.
逐年被引趋势
暂无年度引用数据
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Bone health and osteoporosis research
Lung Cancer Diagnosis and Treatment · Medical Imaging and Pathology Studies